BFRA

Q: What is the price of Biofrontera (BFRA) today?

The price of Biofrontera (BFRA) today is $ 0.00, with return of 0% compared to the last year. The price of Biofrontera (BFRA) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Biofrontera (BFRA) and international markets.

Q: When does Biofrontera (BFRA) pay dividends?

Biofrontera (BFRA) did not distribute dividends in the last year.

Q: Is Biofrontera (BFRA) worth it?

Currently, Biofrontera (BFRA) is priced at $ 0.00, with a P/E of 0.00%, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Biofrontera (BFRA) stock?

Investing in stocks of Biofrontera (BFRA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Biofrontera (BFRA) yield today?

The yield of Biofrontera (BFRA) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Biofrontera (BFRA) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Biofrontera AG

Price

$ -

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

price BFRA

BVMF

BFRA

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of BFRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BFRA

review the fundamentals of Biofrontera shares

P/E

0.00

Sector: -3.40 Industry: -3.40

P/SALES RATIO (PSR)

0.00

Sector: -3.36 Industry: -3.36

P/BV

0.00

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-205.16%

Sector: -62.78% Industry: -62.78%

ROE

-893.55%

Sector: -68.26% Industry: -68.26%

ROIC

Sector: -1,140.39% Industry: -1,140.39%

NET MARGIN

-14.76%

Sector: -41.80% Industry: -41.80%

GROSS MARGIN

89.44%

Sector: 39.33% Industry: 39.33%

OPERATING MARGIN

2.78%

Sector: -41.58% Industry: -41.58%

P/EBITDA

0.00

Sector: -3.48 Industry: -3.48

P/EBIT

0.00

Sector: -3.60 Industry: -3.60

P/ASSET

0.00

Sector: 1.42 Industry: 1.42

BVPS

181,659.48

Sector: 1.79 Industry: 1.79

EPS

-999,999.99

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.23

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

1.43%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

5.32%

Sector: - Industry: -

Fundamentals BFRA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.42	0.00	0.00%	2.51%	$ 487.73 B	27.26%
PFE	14.23	1.50	10.56%	6.95%	$ 139.89 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.73	7.92	57.70%	3.54%	$ 211.67 B	32.78%
MRK	12.83	0.00	0.00%	3.31%	$ 244.20 B	29.63%
AZN	30.03	6.14	20.45%	1.72%	$ 282.28 B	16.17%
BMY	15.59	5.06	32.47%	5.36%	$ 94.17 B	12.57%
GILD	19.41	7.34	37.80%	2.48%	$ 157.41 B	27.88%
ZTS	20.40	10.02	49.11%	1.58%	$ 54.07 B	28.21%
HALO	13.82	16.33	118.17%	0.00%	$ 8.23 B	47.91%
REGN	17.17	2.54	14.79%	0.35%	$ 78.61 B	32.13%
AMGN	25.92	18.88	72.82%	2.78%	$ 181.60 B	19.47%
VRTX	29.73	6.31	21.22%	0.00%	$ 109.25 B	31.35%
MCK	26.63	-185.79	-697.75%	0.34%	$ 107.39 B	1.04%
ADMA	19.60	9.52	48.57%	0.00%	$ 4.11 B	42.87%
CAH	31.26	-18.26	-58.40%	0.97%	$ 49.86 B	0.68%
BIIB	16.02	1.42	8.83%	0.00%	$ 25.77 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BFRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.13%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	02/25/2021	03/04/2021	0,10390000
Dividend	08/17/2020	08/24/2020	0,02360000
Dividend	03/19/2020	03/30/2020	0,02210000

ABOUT THE COMPANY Biofrontera

Biofrontera AG

Average user rating I10

4.0 (0 people)

United States

28 years

Founded: 1997

2018

Time since IPO - 7 years

149

Employees

The Company Biofrontera AG (United States), is listed on Nasdaq with a market cap of $ 55.02 Millions, having an equity of $ 5.15 Trillions.

With a total of 149 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 311.95 Trillions, which generated a loss in the amount of $ -46.03 Trillions.

As for its main indicators, the Company has a P/E ratio of 0.00, a P/BV ratio of 0.00 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker BFRA.

Market cap

$ 55.02 Millions

Equity

$ 5.15 Trillions

US$ 5,151,625,168,378.40

Assets

$ 22.44 Trillions

US$ 22,437,037,247,130.00

Total Shares Outstanding

28.36 Millions

28,358,000

Average Daily Trading Volume

$ 2.18 Billions

US$ 2,175,704,951.59

Sector

Health Care

Industry

Biotechnology

BFRA

BFRA revenue and profits

Financial Results BFRA

DRAG THE FRAME TO SEE MORE DATA

BFRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

MCK - McKesson

$ 870.21 41,86% (12M)

P/E

26.63

0.34%

ROE

-697.75%

P/BV

-185.79

CAH - Cardinal Health

$ 211.20 76,36% (12M)

P/E

31.26

0.97%

ROE

-58.40%

P/BV

-18.26

JNJ - Johnson & Johnson

$ 206.05 37,46% (12M)

P/E

19.42

2.51%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.40 3,83% (12M)

P/E

12.83

3.31%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.22 6,38% (12M)

P/E

14.23

6.95%

ROE

10.56%

P/BV

1.50

ABBV - AbbVie

$ 229.51 34,15% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 91.52 40,77% (12M)

P/E

30.03

1.72%

ROE

20.45%

P/BV

6.14

BMY - Bristol-Myers Squibb

$ 47.76 --14,71% (12M)

P/E

15.59

5.36%

ROE

32.47%

P/BV

5.06

MCK - McKesson

$ 870.21 41,86% (12 M)

P/L

26.63

0.34%

ROE

-697.75%

P/VP

-185.79

CAH - Cardinal Health

$ 211.20 76,36% (12 M)

P/L

31.26

0.97%

ROE

-58.40%

P/VP

-18.26

JNJ - Johnson & Johnson

$ 206.05 37,46% (12 M)

P/L

19.42

2.51%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.40 3,83% (12 M)

P/L

12.83

3.31%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.22 6,38% (12 M)

P/L

14.23

6.95%

ROE

10.56%

P/VP

1.50

ABBV - AbbVie

$ 229.51 34,15% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 91.52 40,77% (12 M)

P/L

30.03

1.72%

ROE

20.45%

P/VP

6.14

BMY - Bristol-Myers Squibb

$ 47.76 --14,71% (12 M)

P/L

15.59

5.36%

ROE

32.47%

P/VP

5.06

Frequently Asked Questions

What is the price of Biofrontera (BFRA) today?

The price of Biofrontera (BFRA) today is $ 0.00, with return of 0% compared to the last year. The price of Biofrontera (BFRA) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Biofrontera (BFRA) and international markets.

When does Biofrontera (BFRA) pay dividends?

Biofrontera (BFRA) did not distribute dividends in the last year.

Is Biofrontera (BFRA) worth it?

Currently, Biofrontera (BFRA) is priced at $ 0.00, with a P/E of 0.00%, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Biofrontera (BFRA) stock?

Investing in stocks of Biofrontera (BFRA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Biofrontera (BFRA) yield today?

The yield of Biofrontera (BFRA) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Biofrontera (BFRA) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BFRA

Biofrontera AG

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of BFRA

review the fundamentals of Biofrontera shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.13%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Biofrontera

Biofrontera AG

United States

28 years

2018

149

PROFIT X PRICE BFRA

Financial Results BFRA

BFRA cash flow

asset growth - BFRA

BFRA balance sheet

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Frequently Asked Questions